Explore
Validate
LearnARP39736_T100
antibody from Aviva Systems Biology
Targeting: MLXIPL
bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [0]
- Comments [0]
- Validations
- Western blot [1]
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ARP39736_T100 - Provider product page
- Provider
- Aviva Systems Biology
- Proper citation
- Aviva Systems Biology Cat#ARP39736_T100, RRID:AB_841556
- Product name
- MLXIPL antibody - N-terminal region (ARP39736_T100)
- Antibody type
- Polyclonal
- Antigen
- The immunogen is a synthetic peptide directed towards the N terminal region of human MLXIPL
- Description
- Protein A purified
- Reactivity
- Human, Mouse, Rat, Bovine, Guinea Pig
- Host
- Rabbit
- Vial size
- 100 μl
- Concentration
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
- Storage
- For short term use, store at 2-8C up to 1 week. For long term storage, store at -20C in small aliquots to prevent freeze-thaw cycles.
No comments: Submit comment
Supportive validation
- Submitted by
- Aviva Systems Biology (provider)
- Main image
- Experimental details
- WB Suggested Anti-MLXIPLAntibody Titration: 1.25µg/mlPositive Control: Jurkat cell lysate
Supportive validation
- Submitted by
- Aviva Systems Biology (provider)
- Main image
- Experimental details
- Immunohistochemistry staining of Human Kidney with Anti-MLXIPL antibody
- Sample type
- Human Kidney
- Validation comment
- This location is supported by literature
- Primary Ab dilution
- 4.0-8.5262
- Secondary Ab
- Secondary Ab
- Secondary Ab dilution
- 0.5ug/mL 0.2ug/mL
- Protocol
- Protocol
